314 related articles for article (PubMed ID: 19904612)
21. Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis.
Briceno V; Zaidi HA; Doucette JA; Onomichi KB; Alreshidi A; Mekary RA; Smith TR
Neurol Res; 2017 May; 39(5):387-398. PubMed ID: 28301972
[TBL] [Abstract][Full Text] [Related]
22. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.
De P; Rees DA; Davies N; John R; Neal J; Mills RG; Vafidis J; Davies JS; Scanlon MF
J Clin Endocrinol Metab; 2003 Aug; 88(8):3567-72. PubMed ID: 12915637
[TBL] [Abstract][Full Text] [Related]
23. Coexistence of ectopic pituitary adenoma and empty sella in a patient with acromegaly : a case report and review of literature.
Hong JF; Ding XH; Wang SS
Neurol India; 2012; 60(3):304-6. PubMed ID: 22824688
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone secreting pituitary microadenomas and empty sella - An under-recognized association?
Liu W; Zhou H; Neidert MC; Schmid C; Bernays RL; Ni M; Zhou D; Jia W; Jia G
Clin Neurol Neurosurg; 2014 Nov; 126():18-23. PubMed ID: 25194306
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
Taweesomboonyat C; Oearsakul T
World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
[TBL] [Abstract][Full Text] [Related]
26. Endocrinological outcomes following endoscopic and microscopic transsphenoidal surgery in 113 patients with acromegaly.
Sarkar S; Rajaratnam S; Chacko G; Chacko AG
Clin Neurol Neurosurg; 2014 Nov; 126():190-5. PubMed ID: 25278017
[TBL] [Abstract][Full Text] [Related]
27. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects.
Doga M; Bonadonna S; Burattin A; Giustina A
Ann Oncol; 2001; 12 Suppl 2():S89-94. PubMed ID: 11762359
[TBL] [Abstract][Full Text] [Related]
28. Ectopic growth hormone-releasing adenoma in the cavernous sinus--case report.
Mitsuya K; Nakasu Y; Nioka H; Nakasu S
Neurol Med Chir (Tokyo); 2004 Jul; 44(7):380-5. PubMed ID: 15347217
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria.
Anik I; Cabuk B; Gokbel A; Selek A; Cetinarslan B; Anik Y; Ceylan S
World Neurosurg; 2017 Dec; 108():278-290. PubMed ID: 28887283
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
31. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
Schwyzer L; Starke RM; Jane JA; Oldfield EH
J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
[TBL] [Abstract][Full Text] [Related]
32. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
Nishioka H; Fukuhara N; Horiguchi K; Yamada S
J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
34. Outcome of Endoscopic Transsphenoidal Surgery for Acromegaly.
Kim JH; Hur KY; Lee JH; Lee JH; Se YB; Kim HI; Lee SH; Nam DH; Kim SY; Kim KW; Kong DS; Kim YH
World Neurosurg; 2017 Aug; 104():272-278. PubMed ID: 28465267
[TBL] [Abstract][Full Text] [Related]
35. [Outcome of surgical treatment for acromegaly performed by a single neurosurgeon and cumulative meta-analysis].
Boeving A; Borba LA; Rodrigues AM; Orichowski EB; Paz Filho GJ; Santos CM; Boguszewski CL
Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):884-92. PubMed ID: 17160212
[TBL] [Abstract][Full Text] [Related]
36. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
[TBL] [Abstract][Full Text] [Related]
37. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
[TBL] [Abstract][Full Text] [Related]
38. Novel use of endogenous GH-measurement directly after transsphenoidal microsurgery in acromegaly treated with pegvisomant.
Lüdecke DK; Crock PA; Bidlingmaier M; Schuppert F
Exp Clin Endocrinol Diabetes; 2013 Aug; 121(8):509-12. PubMed ID: 23765756
[TBL] [Abstract][Full Text] [Related]
39. A Case of acromegaly associated with subclinical Cushing's disease.
Tsuchiya K; Ohta K; Yoshimoto T; Doi M; Izumiyama H; Hirata Y
Endocr J; 2006 Oct; 53(5):679-85. PubMed ID: 16926523
[TBL] [Abstract][Full Text] [Related]
40. Quantification of specific growth patterns and frequency of the empty sella phenomenon in growth hormone-secreting pituitary adenomas.
Bier G; Hempel JM; Grimm F; Ernemann U; Bender B; Honegger J
Eur J Radiol; 2018 Jul; 104():79-86. PubMed ID: 29857870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
